Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods

Journal of Medical Microbiology

Volumn 60, Issue 2, 2011, Pages 162-171

  Cho, Eun Jung ^a   Do, Jin Hwan ^a   Kim, Yoon Sun ^a   Bae, Sumi ^a   Ahn, Woong Shick ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

FEMALE; HUMANS; MICROARRAY ANALYSIS; MICROSPHERES; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIROLOGY;

EID: 79251498022     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.021642-0     Document Type: Article

References (21)

1. Bhatla, N. & Moda, N. (2009). The clinical utility of HPV DNA testing in cervical cancer screening strategies. Indian J Med Res 130, 261-265.
2. Coutlée, F., Rouleau, D., Ferenczy, A. & Franco, E. (2005). The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol 16, 83-91.
3. Coutlée, F., Mayrand, M., Roger, M. & Franco, E. L. (2009). Detection and typing of human papillomavirus nucleic acids in biological fluids. Public Health Genomics 12, 308-318.
4. Geraets, D. T., Heideman, D. A. M., De Koning, M. N. C., Snijders, P. J. F., Van Alewijk, D. C. J. G., Meijer, C. J. L. M., Van Doorn, L. J. & Quint, W. G. V. (2009). High-throughput genotyping of high-risk HPV by the digene HPV genotyping LQ test using GP5+/6+-PCR and xMAP technology. J Clin Virol 46, S21-S26.
5. Gillio-Tos, A., De-Marco, L., Ghisetti, V., Snijders, P. J., Segnan, N., Ronco, G. & Merletti, F. (2006). Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol 36, 126-132.
6. Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R. & Apple, R. J. (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol 38, 357-361.
7. Han, J., Swan, D. C., Smith, S. J., Lum, S. H., Sefers, S. E., Unger, E. R. & Tang, Y.-W. (2006). Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol 44, 4157-4162. (Pubitemid 44737263)
8. Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A. B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A. & Dubin, G. (2006). Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet 367, 1247-1255.
9. Hesselink, A. T., Bulkmans, N. W. J., Berkhof, J., Lorincz, A. T., Meijer, C. J. L. M. & Snijders, P. J. F. (2006). Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol 44, 3680-3685.
10. Jiang, H. L., Zhu, H. H., Zhou, L. F., Chen, F. & Chen, Z. (2006). Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J Med Microbiol 55, 715-720.
11. Kawana, K., Yasugi, T. & Taketani, Y. (2009). Human papillomavirus vaccines: current issues & future. Indian J Med Res 130, 341-347.
12. Meijer, C. J., Snijders, P. J. & Castle, P. E. (2006). Clinical utility of HPV genotyping. Gynecol Oncol 103, 12-17.
13. Muñoz, N., Bosch, F. X., De Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., Meijer, C. J. L. M. & International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
14. Ochi, H., Kondo, K., Matsumoto, K., Oki, A., Yasugi, T., Furuta, R., Hirai, Y., Yoshikawa, H. & Kanda, T. (2008). Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia. Clin Vaccine Immunol 15, 1536-1540.
15. Oh, Y., Bae, S. M., Kim, Y.-W., Choi, H.-S., Nam, G.-H., Han, S.-J., Park, C. H., Cho, Y., Han, B.-D. & Ahn, W. S. (2007). Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci 98, 549-554. (Pubitemid 46562746)
16. Remmerbach, T. W., Brinckmann, U. G., Hemprich, A., Chekol, M., Kühndel, K. & Liebert, U. G. (2004). PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30, 302-308.
17. Schmitt, M., Bravo, I. G., Snijders, P. J., Gissmann, L., Pawlita, M. & Waterboer, T. (2006). Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 44, 504-512.
18. 10 line probe assay. J Clin Microbiol 40, 979-983.
19. Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M. & other authors (2006). Immunologic responses following administration of a vaccine targeting human papillomavirus types 6/11/16, and 18. Vaccine 24, 5571-5583.
20. Wallace, J., Woda, B. A. & Pihan, G. (2005). Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn 7, 72-80.
21. Winder, D. M., Ball, S. L. R., Vaughan, K., Hanna, N., Woo, Y. L., Fränzer, J., Sterling, J. C., Stanley, M. A., Sudhoff, H. & Goon, P. K. C. (2009). Sensitive HPV detection in oropharyngeal cancers. BMC Cancer 9, 440.